Skip to main content

Table 2 Distribution of systemic antibiotic subgroupsa by age group in 2008 (children and adolescents ≤18 years)

From: Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study

  Aarhus (DK) Emilia Romagna (IT) GePaRD (DE) PHARMO (NL) THIN (UK)
  ≤ 4 5-9 10-14 15-18 0-18 ≤ 4 5-9 10-14 15-18 0-18 ≤ 4 5-9 10-14 15-18 0-18 ≤ 4 5-9 10-14 15-18 0-18 ≤ 4 5-9 10-14 15-18 0-18
Tetracyclines - - 0.3 1.7 0.4 <0.1 <0.1 1.1 4.1 0.6 <0.1 0.1 3.8 11.7 3.3 <0.1 0.1 9.6 24.2 6.7 <0.1 <0.1 8.6 26.3 7.8
Broad spectrum penicillins 47.8 24.2 12.7 14.8 31.0 62.4 57.5 51.3 44.0 57.4 28.4 23.5 23.3 17.5 23.8 73.3 60.3 43.0 21.8 54.9 62.0 47.3 34.7 20.8 44.2
Narrow spectrum penicillins 42.6 63.8 69.4 48.5 51.7 <0.1 0.1 0.2 0.2 0.1 11.7 19.8 15.4 12.7 14.8 4.9 9.7 13.7 12.7 8.9 16.0 28.1 31.8 25.1 23.5
Second generation cephalosporins <0.1 <0.1 <0.1 <0.1 <0.1 5.1 4.7 3.0 2.0 4.3 27.5 21.1 15.6 8.7 19.4 0.1 0.3 0.1 0.1 0.2 1.2 1.1 0.8 0.4 0.9
Third generation cephalosporins - - - <0.1 <0.1 14.7 14.8 13.9 10.6 14.1 8.8 5.9 5.2 3.8 6.3 <0.1 <0.1 0.1 0.2 0.1 0.1 0.1 0.1 <0.1 0.1
Sulfonamides/trimethoprim 0.9 2.8 3.5 9.5 3.6 0.4 0.5 0.7 1.0 0.5 3.8 5.4 5.5 7.8 5.4 5.3 7.1 6.3 6.5 6.1 4.9 6.4 5.2 7.7 5.9
Macrolides 8.3 7.6 13.0 24.7 12.5 16.7 21.0 27.2 28.9 20.7 16.7 18.8 24.9 23.5 20.3 15.2 17.4 18.7 14.2 16.0 12.2 11.7 13.7 12.6 12.5
Nitrofuran derivatives 0.1 1.4 0.8 0.7 0.6 <0.1 <0.1 <0.1 <0.1 <0.1 0.2 0.6 0.4 0.4 0.4 0.7 4.3 6.9 16.3 5.8 0.2 0.5 0.4 0.8 0.4
Others 0.2 0.2 0.3 0.3 0.2 0.6 1.4 2.8 9.1 2.1 2.8 4.7 5.9 13.9 6.3 0.5 0.9 1.8 3.9 1.4 3.4 4.8 4.7 6.3 4.6
  1. aIn column percentages, based on total number of systemic antibiotic prescriptions per age group.